TW201129357A - Novel compound, antitumor agent, and medicines, food or cosmetics with antitumor action - Google Patents

Novel compound, antitumor agent, and medicines, food or cosmetics with antitumor action

Info

Publication number
TW201129357A
TW201129357A TW100105402A TW100105402A TW201129357A TW 201129357 A TW201129357 A TW 201129357A TW 100105402 A TW100105402 A TW 100105402A TW 100105402 A TW100105402 A TW 100105402A TW 201129357 A TW201129357 A TW 201129357A
Authority
TW
Taiwan
Prior art keywords
novel compound
medicines
food
antitumor
cosmetics
Prior art date
Application number
TW100105402A
Other languages
Chinese (zh)
Other versions
TWI436764B (en
Inventor
Tomihisa Ohta
Fumihide Takano
Takanori Tatsuno
Tomoya Takahashi
Takayuki Shimizu
Original Assignee
Arsoa Honsha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arsoa Honsha Corp filed Critical Arsoa Honsha Corp
Publication of TW201129357A publication Critical patent/TW201129357A/en
Application granted granted Critical
Publication of TWI436764B publication Critical patent/TWI436764B/en

Links

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Pyrane Compounds (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

An objective of the present invention is to provide a novel compound free of side effects, safe in use, and with excellent antitumor action; an antitumor agent free of side effects, safe in use, and with excellent antitumor action; and medicines, food or cosmetics free of side effects, safe in use, and with excellent antitumor action. To achieve the objective, the present invention provides a novel compound A represented by the following formula (1), an antitumor agent containing the novel compound A, and medicines, food or cosmetics containing the novel compound A.
TW100105402A 2010-02-19 2011-02-18 Novel compounds, antineoplastic agents, and pharmaceuticals, foods or cosmetics that have anti-tumor effects TWI436764B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010034621 2010-02-19

Publications (2)

Publication Number Publication Date
TW201129357A true TW201129357A (en) 2011-09-01
TWI436764B TWI436764B (en) 2014-05-11

Family

ID=44489029

Family Applications (1)

Application Number Title Priority Date Filing Date
TW100105402A TWI436764B (en) 2010-02-19 2011-02-18 Novel compounds, antineoplastic agents, and pharmaceuticals, foods or cosmetics that have anti-tumor effects

Country Status (3)

Country Link
JP (1) JP5620847B2 (en)
CN (2) CN103467293B (en)
TW (1) TWI436764B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI417091B (en) * 2010-02-19 2013-12-01 Arsoa Honsha Corp Anti-obesity agents and pharmaceuticals, foods or cosmetics that have a fat accumulation inhibitory effect
TWI610676B (en) * 2015-07-04 2018-01-11 Aob Keioh Group Corp Method for producing nerve cell death inhibitor, anti-Alzheimer's disease agent, anti-brain hypofunction agent, medicine having anti-Alzheimer's disease effect or anti-brain function, and nerve cell death inhibitor

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115385795B (en) * 2022-10-11 2023-11-17 广西中医药大学赛恩斯新医药学院 Preparation method and application of Rhinacanthus nasuta (L.) kurz naphthoquinone monomer Rhinacanthin-C

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002053481A (en) * 2000-08-10 2002-02-19 Arsoa Honsya Corp Anti-malignant tumor agent
US8221766B2 (en) * 2004-12-22 2012-07-17 Avon Products, Inc. Use of plant extracts to prevent and/or reduce the signs of subjective discomfort and/or irritation in the topical application of cosmetic products
US7618662B2 (en) * 2004-12-22 2009-11-17 Avon Products, Inc Use of natural plant extracts in cosmetic compositions

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI417091B (en) * 2010-02-19 2013-12-01 Arsoa Honsha Corp Anti-obesity agents and pharmaceuticals, foods or cosmetics that have a fat accumulation inhibitory effect
TWI610676B (en) * 2015-07-04 2018-01-11 Aob Keioh Group Corp Method for producing nerve cell death inhibitor, anti-Alzheimer's disease agent, anti-brain hypofunction agent, medicine having anti-Alzheimer's disease effect or anti-brain function, and nerve cell death inhibitor

Also Published As

Publication number Publication date
CN103467293A (en) 2013-12-25
JP5620847B2 (en) 2014-11-05
CN102167687A (en) 2011-08-31
CN102167687B (en) 2014-03-12
TWI436764B (en) 2014-05-11
CN103467293B (en) 2015-06-10
JP2011190250A (en) 2011-09-29

Similar Documents

Publication Publication Date Title
MY179412A (en) Pyridine-2-amides useful as cb2 agonists
MY184978A (en) Pyridin-2-amides useful as cb2 agonists
IN2012DN00736A (en)
MX2012012530A (en) N3-substituted-n1-sulfonyl-5-fluoropyrimidinone derivatives.
PH12016500225A1 (en) Novel quinoline-substituted compound
MY162146A (en) Pharmaceutical composition
IN2012DN00692A (en)
UA114656C2 (en) Novel pyridine derivatives
MX2013004004A (en) Pyrrolidinones as metap2 inhibitors.
MY182328A (en) Pyridine-2-amides useful as cb2 agonists
MX2014004858A (en) Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies.
MX2015008295A (en) Cosmetic composition.
MX342947B (en) Treatment of type 2 diabetes.
IN2015DN03998A (en)
MY171201A (en) New carbamate glycolipid and use thereof
MX2012001620A (en) N1-acyl-5-fluoropyrimidinone derivatives.
PH12015502429A1 (en) Dicarboxylic acid compound
IN2014DN10449A (en)
PH12015502241A1 (en) (r) -nifuratel, its use for the treatment of infections and synthesis of (r) and (s) -nifuratel
PH12015500585A1 (en) Modified hyaluronic acid derivatives and use thereof
MX2012010127A (en) Derivatives of aminoindanes, their preparation and their application in therapeutics.
TW201129358A (en) Antiobesity agent and medicines, food or cosmetic with function in inhibition of lipid accumulation
TW201129357A (en) Novel compound, antitumor agent, and medicines, food or cosmetics with antitumor action
GB201020397D0 (en) Compounds
TN2012000381A1 (en) 2-aldoximino-5-fluoropyrimidine derivatives